Review
Sep 2026
Beyond maximum grade: key regulatory considerations in adverse event reporting.
Key challenges and opportunities related to measuring cumulative and long-term toxicity burden, incorporating patient-reported outcomes, improving adverse event reporting quality and efficiency in clinical trials, and leveraging real-world data, registries, and emerging technologies, such as artificial intelligence and...
Kyriaki Tzogani, T. El-Galaly, N. Everest et al.
· The Lancet Haematology · 2 citations